Skip to main content
Premium Trial:

Request an Annual Quote

Ipsogen, Cleveland Clinic Go Hunting for Breast Cancer Biomarkers

NEW YORK, Oct. 27 (GenomeWeb News) - Ipsogen will collaborate with The Cleveland Clinic to identify molecular markers in early-stage breast cancer, the company said today.


Ipsogen, of Marseille, France, will use its gene expression-profiling and bioinformatics tools to find markers that predict patient risk for breast cancer recurrence. Researchers at The Cleveland Clinic will contribute its expertise in breast cancer management.


Terms of the collaboration were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.